You are here

Article Text

Article menu
Download PDFPDF
DTB select
MHRA issues two updates on fluoroquinolone safety

Abstract

Overview of: Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: reminder of the risk of disabling and potentially long-lasting or irreversible side effects. Drug Safety Update 2023;17:1. Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: suicidal thoughts and behaviour. Drug Safety Update 2023;17:2.

  • Drug-Related Side Effects and Adverse Reactions
  • Health Care Quality, Access, and Evaluation

https://doi.org/10.1136/dtb.2023.000069

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors DTB Team.

    • Provenance and peer review Commissioned; internally peer reviewed.